How much does Aspire Pharma Limited make?

Aspire Pharma Limited reported revenue of £118m and £21.8m profit in the year to 31 Dec 2025, according to its accounts filed at Companies House.

How many employees does Aspire Pharma Limited have?

Aspire Pharma Limited reported an average of 114 employees in the year to 31 Dec 2025.

Is Aspire Pharma Limited profitable?

Yes — Aspire Pharma Limited reported a profit of £21.8m in the year to 31 Dec 2025.

Company No. 06828501 · Incorporated 24 Feb 2009

Aspire Pharma Limited

Registered name: ASPIRE PHARMA LIMITED

Part of Aphl 2 Limited group

Aspire Pharma Limited made £118m revenue and £21.8m profit in the year to 31 Dec 2025. read from filing text

Aspire Pharma Limited’s revenue grew 3% to £118m in the year to 31 Dec 2025, with £21.8m profit and 114 employees. The company is classified under “wholesale of pharmaceutical goods” and is based in Godalming; we hold 4 years of its filed accounts.

Full P&L filedSection G · Wholesale and retail trade; repair of motor vehiclesSIC 46460Wholesale of pharmaceutical goods

Status: Active
Location: Godalming, South East
Age: 17 yrs · since 2009
Type: Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently. From the filing: “The company is wholly owned by APHL 2 Limited, a company registered in England. The smallest company within which the accounts are consolidated is APHL 2 Limited.”

Latest accounts · year to 31 Dec 2025

Key figures

Revenue

£118m

Growth ▲2.8%

Profit

£21.8m

Growth ▼5.5%

Profit margin

18.5%

Gross 39.8%

Employees

114

Change ▲14%

Profit / employee

£191k

Revenue/employee £1m

Profitable streak

4yrs

Consecutive profitable years in our data

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

4 filed years

Financial history

Multi-year financials, oldest to newest
Year to	31 Dec 2022	31 Dec 2023	31 Dec 2024	31 Dec 2025
Disclosure	Full P&Lread from filing text	Full P&Lread from filing text	Full P&Lread from filing text	Full P&Lread from filing text
Profit & loss
Revenue (turnover)	£81.7m	£99.1m	£115m	£118m
Cost of sales	£46.1m	£63.2m	£70.4m	£71.2m
Gross profit	£35.6m	£35.9m	£44.6m	£47m
Operating profit	£20.5m	£20.2m	£24.7m	£24.1m
Profit before tax	£20.6m	£20.3m	£24.9m	£24.2m
Profit after tax	£19.8m	£19.5m	£23.1m	£21.8m
Profit (best available)	£19.8m	£19.5m	£23.1m	£21.8m
Staff costs	£3.8m	£4.7m	£7.3m	£8m
Employees (average)	71	79	100	114
Ratios
Profit margin	24.3%	19.7%	20.1%	18.5%
Gross margin	43.5%	36.2%	38.8%	39.8%
Revenue per employee	£1.2m	£1.3m	£1.1m	£1m
Profit per employee	£279k	£247k	£231k	£191k
Growth (year on year)
Revenue growth	—	▲21.3%	▲16%	▲2.8%
Profit growth	—	▼1.5%	▲18.2%	▼5.5%
Headcount growth	—	▲11.3%	▲26.6%	▲14%
Balance sheet — indirect signals, not revenue
Cash at bank	£8.8m	£9.7m	£8.5m	£7m
Net assets	£48.2m	£48.5m	£65.8m	£87.6m
Fixed assets	£12.4m	£14.1m	£24.3m	£43.6m
Current assets	£52.7m	£63.2m	£72m	£80m
Debtors	£13.2m	£13.4m	£16.4m	£25.1m
Source	FullAccounts · bulk data Jul 2024	FullAccounts · bulk data Jul 2024	FullAccounts · bulk data Jul 2025	FullAccounts · bulk data Aug 2026

Derived from the latest filing

How the business works

Profit margin: 18.5%; Profit ÷ revenue.
Gross margin: 39.8%; Gross profit ÷ revenue. High for software and services.
Revenue per employee: £1m; Revenue ÷ average employees.
Profit per employee: £191k; Profit ÷ average employees.
Cash conversion: —; Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue: 36.9%; Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue: —; Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue: 21.2%; Money owed by customers. Low = customers pay quickly.

Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets: ▲33%; Now £87.6m
Cash at bank: ▼17%; Now £7m
Headcount: ▲14%; Now 114
Deferred income: —; Now —
Fixed assets: ▲79%; Now £43.6m

Corporate ownership

Group structure

Ownership chain

Aphl 2 Limitedultimate parent75–100%
Aspire Pharma Limitedthis company

Bands show the share of ownership each company holds in the one below it.

Subsidiaries (4)

Cenote Pharma LimitedFigures not disclosed
Charlwood Pharma LimitedFigures not disclosed
Dermato Logical LimitedFigures not disclosed
Saint-Germain Pharma LtdFigures not disclosed

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Companies House profile Filing history & original accounts

Latest figures from FullAccounts for the year to 31 Dec 2025 (profit £21.8m), from the Companies House accounts bulk data published Aug 2026. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.